Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of diagnostic tests

J Schachter1

  • 1Department of Laboratory Medicine, University of California, San Francisco.

Upsala Journal of Medical Sciences. Supplement
|January 1, 1991
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same journal

Abstracts for the 4th International Conference on Bartonella as Emerging Pathogens, 26-28 AUgust 2005, Uppsala, Sweden.

Upsala journal of medical sciences. Supplement·2005
Same journal

Abstracts of the 22nd Conference of European Comparative Endocrinologists. 24-28 August 2004, Uppsala, Sweden.

Upsala journal of medical sciences. Supplement·2004
Same journal

Nordic Congress on Spinal Surgery. Stockholm, Sweden, September 25-26, 1997. Abstracts.

Upsala journal of medical sciences. Supplement·1999
Same journal

Proceeding of the 45th annual meeting of the Scandinavian Neurosurgical Society. Uppsala, June 9-12, 1993. Abstracts.

Upsala journal of medical sciences. Supplement·1993
Same journal

Urethral discharge in males.

Upsala journal of medical sciences. Supplement·1991
Same journal

HIV prevention as exemplified by action taken in Italy.

Upsala journal of medical sciences. Supplement·1991
See all related articles